Skip to main content
OpenTrials
Completed

NCT Number: NCT07825636

Sensorimotor Function in COPD

The aim of this study was to investigate the level of sensorimotor function impairment according to disease stage in individuals with Chronic Obstructive Pulmonary Disease (COPD) and to determine whether functional differences exist between individuals with COPD and healthy controls.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Obstructive Pulmonary Disease (COPD) Chronic Disease Cognition Disorders Cognitive Dysfunction Disease Attributes Lung Diseases Lung Diseases, Obstructive Mental Disorders Neurocognitive Disorders Neurologic Manifestations Pain Pathologic Processes Pathological Conditions, Signs and Symptoms Pulmonary Disease, Chronic Obstructive Respiratory Tract Diseases Signs and Symptoms

Age range

40 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Alanya Alaaddin Keykubet University

Antalya, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Individuals diagnosed with COPD,

  • Aged 40-65 years, who volunteer to participate in the study,
  • Who do not have additional musculoskeletal disorders, neurological or cardiorespiratory problems, or respiratory failure (not using long-term home oxygen therapy or non-invasive mechanical ventilation) will be included.

Inclusion criteria

for Healthy Individuals:

  • Individuals aged 40-65 years who volunteer to participate in the study,
  • Who do not have additional musculoskeletal disorders, neurological or cardiorespiratory problems,
  • Who do not have communication problems will be included.

Exclusion criteria

Exclusion criteria

for Individuals with COPD

  • Individuals with uncorrected visual and hearing impairment,
  • Individuals with a diagnosed serious chronic disease (neurological disease, cancer, chronic heart failure, etc.).

Exclusion criteria

for Healthy Individuals

  • Individuals with uncorrected visual and hearing impairment,
  • A diagnosed serious chronic disease (neurological disease, cancer, chronic heart failure, etc.) will be excluded from the study.

Treatment and study plan

Primary outcomes

  1. Montreal Cognitive Assessment

    Time frame: Enrollment

    Cognitive function was assessed using the Montreal Cognitive Assessment. The scale evaluates various cognitive domains, such as executive functions, visuospatial skills, attention, memory, language, abstraction, and orientation. The total score was calculated out of 30 points.

  2. Pain Pressure Threshold and Tolerance

    Time frame: Enrollment

    Pain threshold and pain tolerance were assessed using a digital pressure algometer (J-Tech Commander algometer, Preston Co., USA). Two measurements were taken from each site, and the mean value was used in the analysis.

  3. Muscle Quality Index

    Time frame: Enrollment

    Muscle quality was assessed using the Muscle Quality Index, calculated based on the duration of the 5-repetition sit-to-stand test, body weight, and leg length.

Secondary outcomes

  1. Lower Extremity Coordination Test

    Time frame: Enrollment

    Lower extremity coordination was assessed using the Lower Extremity Coordination Test, performed as a heel-to-toe tapping task. The test is repeated three times over a 20-second period, and the best result is used in the analysis.

Sponsors and collaborators

Lead sponsor

Alanya Alaaddin Keykubat University

Other

Registry information

Official study title

Sensorimotor Function Impairment in Chronic Obstructive Pulmonary Disease

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Sep 17, 2026
Registry last updated
Sep 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.